Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Communications & Outreach

Communications & Outreach

                        FDA Commission Validation
          Non-Binding Agreements with the FDA Office of Regulatory Affairs
          ORA’s Return-on-Investment Assessment  for State Partnership Agreements
          Commissioning
          Information Sharing
          Methods Of Communication
          Regulatory Associations
          State and Local Inquiries


                        News & Events Home
          For Federal, State, Local, Tribal, and Territorial Officials
          Communications & Outreach
          Non-Binding Agreements with the FDA Office of Regulatory AffairsCommunications & Outreach Non-Binding Agreements with the FDA Office of Regulatory Affairs
  
  	
    Share
    Post
    Linkedin

    Email
    PrintWhat is a Non-Binding Agreement?
	When is a Non-Binding Agreement Be appropriate?
	What is a Memorandum of Understanding?
	What is the difference between a Memorandum of Agreement and a Memorandum of Understanding?
	Where can I find existing Memorandums of Understanding?
	Who can I contact to learn more?In FDA, the Office of Regulatory Affairs (ORA) has utilized partnerships for more than four decades as a way of advancing public health goals and strengthening existing relationships with partnering agencies. FDA’s goal is to leverage available resources in the most efficient and effective manner by building on the knowledge, skills, and abilities of FDA and its partners.

What is a Non-Binding Agreement?

Non-binding agreements are between an ORA office and any federal, state, local, territorial, or tribal (SLTT) agencies, associations, academia, or other entities.  The term “agreement” in this training is collectively used to identify any non-binding agreement unless specifically noted. The term “partnership” is a general term to describe the relationship between entities.  The term “Partnership Agreements” (PAs) are a specific type of Memorandum of Understanding detailing a domestic mutual reliance relationship down to the activity level to carry out the mission of advancing public health. PA’s can be used to support funding opportunities such as cooperative agreements or grants.

When is a Non-Binding Agreement Appropriate?

Non-Binding Agreements are appropriate when FDA and the partner organization agree to demonstrate mutual commitment to shared goals and objectives with no obligation of fiscal resources (which are required in contracts, grants, and cooperative agreements).

What is a Memorandum of Understanding?

A Memorandum of Understanding (MOU) is a formal agreement between the Food and Drug Administration (FDA) and federal, state, or local government agencies; academic institutions; and other entities (e.g., non-profit organizations). The MOU constitutes an understanding between the parties but is a non-binding agreement. It is FDA's policy to enter into MOUs with other entities whenever there is a need to define lines of authority or responsibility or to clarify cooperative procedures. The intent of the MOU is to improve consumer protection through more effective use of collective resources and to eliminate duplication of activities.

What is the difference between a Memorandum of Agreement and a Memorandum of Understanding?

The difference between a Memorandum of Understanding (MOU) and a Memorandum of Agreement (MOA) is that an MOU is used for simple common-cause agreements which are not legally binding. An MOA, on the other hand, establishes common legal terms that establish a “conditional agreement” where the transfer of funds for services is anticipated. As such the term MOA shall NOT be used in place of an MOU or Partnership Agreement.

Where can I find existing Memorandums of Understanding?

A curated list of agency wide memorandums of understanding for academic institutions, domestic organizations and agencies, as well as non-profit entities can be found at:FDA Memoranda of Understanding | FDA

Who can I contact to learn more?

General questions may be directed to the Office of Partnerships' general mailbox: op.feedback@fda.hhs.gov.

                                                                                  Content current as of:
      11/09/2023Communications & Outreach

          
                        FDA Commission Validation
          Non-Binding Agreements with the FDA Office of Regulatory Affairs
          ORA’s Return-on-Investment Assessment  for State Partnership Agreements
          Commissioning
          Information Sharing
          Methods Of Communication
          Regulatory Associations
          State and Local Inquiries


                        News & Events
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop